Giovanni Sitia

12PUBLICATIONS
97CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsInnate immunityGroundwater quality processes and contaminated land assessmentNanoscale characterisation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jan 08, 2026
TIGIT disruption rescues the antitumor activity of low avidity TCR-engineered T cells by increasing TCR signal strength.

Martina Spiga, Alessia Potenza, Zulma Magnani

|Dec 24, 2025
STAT2 Promotes Tumor Growth in Colorectal Cancer Independent of Type I IFN Receptor Signaling.

Jorge Canar, Madeline Bono, Amy Alvarado

|Feb 14, 2025
Functional Polarization of Liver Macrophages by Glyco Gold Nanoparticles.

Jennifer Fernandez Alarcon, Patricia Perez Schmidt, Nicolo Panini

|Apr 25, 2023
Long-term retention of gold nanoparticles in the liver is not affected by their physicochemical characteristics.

Jennifer Fernandez Alarcon, Mahmoud Soliman, Tanja Ursula Lüdtke

|Apr 13, 2023
Variations in Biodistribution and Acute Response of Differently Shaped Titania Nanoparticles in Healthy Rodents.

Martina B Violatto, Giovanni Sitia, Laura Talamini

|Feb 15, 2023
Harnessing the reverse cholesterol transport pathway to favor differentiation of monocyte-derived APCs and antitumor responses.

Laura Raccosta, Maura Marinozzi, Susan Costantini

Pageof 2